Zacks Investment Research downgraded shares of HESKA CORP (HSKA) from NEUTRAL to UNDERPERFORM on January 16, 2013, with a target price of $8.00.
Heska Corporation is focused on the discovery, development and marketing of companion animal health products. In addition to manufacturing certain of companion animal products, the company's primary manufacturing subsidiary, Diamond Animal Health, Inc., also manufactures animal health vaccine products which are marketed and distributed by third parties. In addition to manufacturing veterinary allergy products for marketing and sale by the company, subsidiaries, Center Laboratories, Inc. and CMG-Heska Allergy Products S.A., also manufacture and sell human allergy products.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on HESKA CORP (HSKA),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment